According to information being released this week, the study was comprised of more than 8,500 people who were at least sixty five years of age, and older, who were diagnosed with type 2 diabetes. From the source, 12.4 percent of those given a sulfonylurea drug experienced a heart attack or other cardiovascular event, compared with 10.4 percent of those who were started on a drug known as metformin.
Sulfonylurea drugs are derivatives that are part of a class of antidiabetic drugs that are used in the
management of diabetes mellitustype 2. They act by increasing insulin release from the beta cells in
Metformin was originally sold as Glucophage. It is an an oral antidiabetic drug in the biguanide class.Source.
Read more here.